Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram and Copper with Temozolomide in Unmethylated GBM
NCT03363659Phase 2Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Mar 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of disulfiram in glioblastoma (GBM), sponsored by Wake Forest University Health Sciences. Started Mar 2018; status: terminated.
02
Drugs
disulfiram
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT03363659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03363659.